21.1.2019
EN
Official Journal of the European Union
C 25/41
Judgment of the General Court of 15 November 2018 — DRH Licensing & Managing v EUIPO — Merck (Flexagil)
(Case T-831/17) (1)
((EU trade mark - Revocation proceedings - EU figurative mark Flexagil - Genuine use of the mark - Article 18(1), second subparagraph,(a) and Article 58(1)(a) of Regulation (EU) 2017/1001 - Form differing in elements which do not alter the distinctive character))
(2019/C 25/53)
Language of the case: German
Parties
Applicant: DRH Licensing & Managing AG (Zurich, Switzerland) (represented by: S. Salomonowitz, lawyer)
Defendant: European Union Intellectual Property Office (represented by: W. Schramek and M. Fischer, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO: Merck KGaA (Darmstadt, Germany)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 17 October 2017 (Case R 2043/2016-4), relating to revocation proceedings between DRH Licensing & Managing and Merck.
Operative part of the judgment
The Court:
1.
Dismisses the action;
2.
Orders DRH Licensing & Managing AG to pay the costs.
(1) OJ C 52, 12.2.2018.
Full & Egal Universal Law Academy